# Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO)

> **NCT02887820** · NA · TERMINATED · sponsor: **Stephen Esper** · enrollment: 15 (actual)

## Conditions studied

- Heart Disease
- Lung Disease

## Interventions

- **DEVICE:** Thromboelastograph

## Key facts

- **NCT ID:** NCT02887820
- **Lead sponsor:** Stephen Esper
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-15
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** A new standard of care was introduced making it impossible to continue with the study. Additionally, some of the blood product and transfusion related outcomes were not collected because this data was not present in the EMR.
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02887820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02887820, "Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02887820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*